Quick Takeaways
- Deep Track Capital, LP filed SCHEDULE 13G/A for Dynavax Technologies Corporation Common Stock, $0.001 par value (DVAX).
- Disclosed ownership: 13%.
- Date of event: 22 Aug 2025.
Deep Track Capital, LP - 22 Aug 2025 SCHEDULE 13G/A Report for Dynavax Technologies Corporation Common Stock, $0.001 par value (DVAX)
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Biotechnology Master Fund, Ltd.
- Symbol
- DVAX
- Shares outstanding
- 117,273,296 shares
- Disclosed Ownership
- 15,726,349 shares
- Ownership
- 13%
- Form type
- SCHEDULE 13G/A
- Filing time
- 25 Aug 2025, 19:47:29 UTC
- Date of event
- 22 Aug 2025
- Previous filing
- 19 Feb 2025
- Next filing
- 11 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Deep Track Capital, LP disclosed 13% ownership in Dynavax Technologies Corporation Common Stock, $0.001 par value (DVAX) on 22 Aug 2025."
What Changed
- Previous schedule filing date: 19 Feb 2025.
- Current filing was accepted on 25 Aug 2025, 19:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Biotechnology Master Fund, Ltd. | 13% | 15,726,349 | 0 | 15,726,349 | /s/ David Kroin | David Kroin, Director | |
| Deep Track Capital, LP | 13% | 15,726,349 | 0 | 15,726,349 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| David Kroin | 13% | 15,726,349 | 0 | 15,726,349 | /s/ David Kroin | David Kroin |